Immunovia

In News

Price to book forward of Immunovia AB – FWB:1YR - TradingView

TradingView - Aug 22, 2026

Equity research Immunovia Q1 2026: Initial commercialisation phase on track - Carlsquare Corporate Finance

Carlsquare Corporate Finance - May 11, 2026

Earnings call transcript: Immunovia Q2 2026 revenue rises 323% as losses persist - Investing.com

Investing.com - Aug 06, 2026

Immunovia AB Revenue Breakdown – OMXSTO:IMMNOV - TradingView

TradingView - Jul 27, 2026

Equity research Immunovia, Q3 2025: US reimbursement in focus - Carlsquare Corporate Finance

Carlsquare Corporate Finance - Nov 27, 2025

Next-Generation Test Shows Sensitivity/Specificity in Pancreatic Cancer - CancerNetwork

CancerNetwork - Mar 26, 2025

Immunovia Publishes Interim Report for April-June 2026 - TradingView

TradingView - Aug 06, 2026

Immunovia’s Pancreatic Cancer Test Up and Running at New Lab - Clinical Lab Products

Clinical Lab Products - Jul 04, 2024

Equity research Immunovia: First impression, Q3 2025 - Successful rights issue to fuel launch and reimbursement progress - Carlsquare Corporate Finance

Carlsquare Corporate Finance - Nov 26, 2025

End of the Year 2024 Letter from Immunovia CEO Jeff Borcherding - Cision News

Cision News - Dec 19, 2024

Immunovia Ab (publ) Stock Price Forecast. Should You Buy IMMNOV.ST? - StockInvest.us

StockInvest.us - Dec 11, 2020

Immunovia Q2 2025 slides: PancreaSure launch plan unveiled amid stock decline - Investing.com

Investing.com - Aug 28, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment